Newsletter

068760 - Celltrion Pharm, Inc.

068760 Summary
Biopharma
Stock Price & Overview
₩40,850 +0 (+0.00%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩40,850  ≈ US$29  ·  Market cap ₩1.8tn (≈ $1.3bn)
Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

068760 DART Filings

DART

Large business group status disclosure — quarterly, individual company

Filing08/27/26title translated
DART

Half-Year Report

Periodic08/14/26title translated
DART

Supplier Payment Terms and Dispute-Resolution Disclosure

Governance08/14/26title translated
DART

Preliminary operating results (fair disclosure)

Filing08/04/26title translated
DART

Future business and management plan (fair disclosure)

Filing07/02/26title translated
DART

Large business group status disclosure — annual and Q1, individual company

Filing06/01/26title translated
DART

Quarterly Report

Periodic05/15/26title translated
DART

Preliminary operating results (fair disclosure)

Filing05/06/26title translated
8 filings on file, grouped where one event produced many. Source: DART, operated by Korea's Financial Supervisory Service.

Similar to 068760

SymbolLast Price
214370Caregen Co., Ltd.₩44,500
+1.5%
347850D & D Pharmatech, Inc.₩49,200
+1.4%
237690ST Pharm Co., Ltd.₩101,200
+2.2%
226950Olix Pharmaceuticals, Inc.₩95,900
+4.5%
140410Mezzion Pharma Co., Ltd.₩65,000
+0.0%
007390Naturecell Co., Ltd.₩23,950
+0.2%
006280GC Biopharma Corp.₩127,600
+0.5%
950160Kolon Tissue Gene, Inc.₩17,100
+1.1%
039200Oscotec, Inc.₩36,600
+1.9%
069620Daewoong Pharma₩116,100
+1.1%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.